Find therapies in clinical trials near you – page 34

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Study of tarlatamab alone or with FOLFIRI chemotherapy for patients with advanced digestive system or unknown origin neuroendocrine carcinomas

Study of tarlatamab alone or with FOLFIRI chemotherapy for patients with advanced digestive system or unknown origin neuroendocrine carcinomas

Study of cagrilintide and semaglutide combination versus placebo in people with type 2 diabetes and painful diabetic peripheral neuropathy

Study of cagrilintide and semaglutide combination versus placebo in people with type 2 diabetes and painful diabetic peripheral neuropathy

Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

Comparing CT-P44 and Darzalex Faspro with lenalidomide and dexamethasone in patients with refractory or relapsed multiple myeloma

Comparing CT-P44 and Darzalex Faspro with lenalidomide and dexamethasone in patients with refractory or relapsed multiple myeloma

Study of ruxolitinib cream for treating hidradenitis suppurativa in adult patients

Study of ruxolitinib cream for treating hidradenitis suppurativa in adult patients

Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

Study on the Safety and Immune Response of PHH-1V81 Booster for Adults Vaccinated Against COVID-19

Study on the Safety and Immune Response of PHH-1V81 Booster for Adults Vaccinated Against COVID-19

Study on COVID-19 Prevention Using Sipavibart and Cilgavimab for Patients with Weakened Immune Systems

Study on COVID-19 Prevention Using Sipavibart and Cilgavimab for Patients with Weakened Immune Systems

Study on Denosumab to Prevent Breast Cancer in Women with BRCA1 Mutation

Study on Denosumab to Prevent Breast Cancer in Women with BRCA1 Mutation

Study on the 9vHPV Vaccine for Preventing Oral HPV Infections in Men Aged 20-45

Study on the 9vHPV Vaccine for Preventing Oral HPV Infections in Men Aged 20-45

Study on the Safety and Effectiveness of Clesrovimab and Palivizumab for Preventing Severe RSV in Infants and Children at High Risk